Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a...
CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials. The segment featured Dr. Sanjay Gupta sharing the story of Alan Ferguson. Mr....
Neuropathic pain is notoriously difficult to treat. Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can originate from infection, metabolic diseases, chemotherapy, trauma...
It’s been more than two years now since the former director of the National Institute of Mental Health wrote about the use of intravenous ketamine for the treatment of mental disorders. He wrote that “ketamine, given intravenously, might be the most...
Good news for patients suffering from Chronic Migraine or new daily persistent headache. A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators at Thomas Jefferson University....
